16-11-2010: The journal Stem Cells has announced Dr. Cinzia Rota as the winner of the annual Stem Cells Young Investigator Award. Co-sponsored by the International Stem Cell Symposium, the $10,000 prize is annually given to a young scientist who is the principal author of a research paper published in Stem Cells and judged to be most important by the Journal editors.
Dr. Rota, from the Mario Negri Institute for Pharmacological Research in Bergamo, Italy, was awarded the prize for her paper entitled 'Life-Sparing Effect of Human Cord Blood-Mesenchymal Stem Cells in Experimental Acute Kidney Injury.'
"The translation of pre-clinical results into therapies will be an important aspect of stem cell research over the next ten years" said Rota. "Students entering this field should know that it is fascinating, with the opportunity to produce results that can potentially be translated in clinical practice, providing hope in areas where traditional medicine does not offer therapeutic opportunities."
Dr. Rota's award winning paper investigated the potential of human cord blood to cure acute kidney injury. The research revealed the potential for of human cord-blood stem cells as a future cell therapy.
"I think that one of the most important things for the public to understand is the different characteristics and regenerative potentials of human embryonic and adult stem cells; that these cells are not interchangeable, and that one or the other may be better for certain clinical applications," said Rota. "Therefore, detailed studies on ESCs, iPS cells, and adult stem cell are all necessary to provide for future cell therapy applications."
This is where you can add this news to your personal favourites
A new study from the University of Southern California (USC) has found a link between recreational marijuana use and an increased risk of developing subtypes of testicular cancer that tend to carry a somewhat worse prognosis. Published in CANCER the findings suggest that the potential cance ... more
Researchers in the United States have developed a medical model for regenerating bladders using stem cells harvested from a patient’s own bone marrow. The research, published in STEM CELLS, is especially relevant for paediatric patients suffering from abnormally developed bladders, but also ... more
The journal Stem Cells has announced Dr. Cinzia Rota as the winner of the annual Stem Cells Young Investigator Award. Co-sponsored by the International Stem Cell Symposium, the $10,000 prize is annually given to a young scientist who is the principal author of a research paper published in ... more
We studied 17,576 members of 166 MLH1 and 224 MSH2 mutation‐carrying families from the Colon Cancer Family Registry. Average cumulative risks of colorectal cancer (CRC), endometrial cancer (EC) and other cancers for carriers were estimated using modified segregation analysis co ... more
Flavonoids have well‐known antioxidant, anti‐inflammatory, and anti‐cancer activities. Isoflavone genistein is considered a potent antioxidant agent against oxidative stress. Although several mechanisms have been proposed, a clear antioxidant mechanism of genistein is still remain ... more
People can get oral cancers from UV (290‐400 nm) exposures. Besides high outdoor UV exposures, high indoor UV exposures to oral tissues can occur when consumers use UV‐emitting tanning devices to either tan or whiten their teeth. We compared the carcinogenic risks of skin to or ... more
Evotec announced the acquisition of all shares in Cell Culture Service GmbH (CCS), a Hamburg-based company which supports the cell culture needs of a customer base of biotech and Pharmaceutical companies. CCS is supplier of custom cells and cell-based reagents such as recombinant assay cell ... more
Evotec AG announced that it has entered into a collaboration with Probiodrug AG. Under the terms of the agreement, Evotec will setup and validate assays to support the pre-clinical and clinical development of glutaminyl cyclase (QC) inhibitors for the treatment of Alzheimer's disease. Gluta ... more
Evotec AG announced that it has received CIR accreditation for a three-year period from the French Ministry of Higher Education and Research.The French R&D tax credit initiative ('Crédit d'Impôt Recherche', CIR) gives eligible research-based French companies, who are subject to corporate ta ... more
by Mario A. Fares, Orla M. Keane, Christina Toft, Lorenzo Carretero-Paulet, Gary W. Jones
Researchers have long been enthralled with the idea that gene duplication can generate novel functions, crediting this process with great evolutionary importance. Empirical data shows that w ... more
by Mario Pujato, Thomas MacCarthy, Andras Fiser, Aviv Bergman
Gene regulatory networks show robustness to perturbations. Previous works identified robustness as an emergent property of gene network evolution but the underlying molecular mechanisms are poorly understood. We used a ... more
by Alina Lelic, Chris P. Verschoor, Mario Ventresca, Robin Parsons, Carole Evelegh, Dawn Bowdish, Michael R. Betts, Mark B. Loeb, Jonathan L. Bramson
As humans age, they experience a progressive loss of thymic function and a corresponding shift in the makeup of the circulating CD ... more
BMI View: We forecast deteriorating prospects for drugmakers in Italy because in addition to a decline in public spending on pharmaceuticals (enforced by price cuts on medicines), company revenue streams are under pressure as hospitals are delaying payments worth billions of dollars. Our be ... more
BMI View: The pharmaceuticals and healthcare sector will be a target of further cost containment, particularly as National Health System (SSN) data for H111, which shows a decline in spending, highlights the success of previous cost-containment efforts.
Headline Expenditure Projections
? ... more
BMI View: Much of the population in the Philippines still struggles to afford medicines, despite the
enforcement of the Universally Accessible Cheaper and Quality Medicines Act of 2008 (previously known
as the ‘Cheaper Medicines Bill’). Part of the problem is the prevalence of counterfeitin ... more
The Mario Negri Institute for Pharmacological Research is a not-for-profit biomedical research organization. It was founded in 1961, and started work in Milan on 1 February 1963. There are now research units in Bergamo, at Ranica near Bergamo and at Santa Maria Imbaro, near Chieti. To a ... more
The IFOM Foundation is a highly technological, non-profit research centre. The research conducted at IFOM aims to understand the molecular processes responsible for the onset and development of cancer. IFOM was established in 1998 by FIRC (the Italian Foundation for Cancer Research). The ai ... more